CTA Volume Dose Reduction Study

Conditions:   Aortic Aneurysm;   Contrast Induced Nephropathy;   Aortic and Arterial AnomaliesIntervention:   Drug: Contrast (Omnipaque)Sponsor:   Milton S. Hershey Medical CenterNot yet recruiting - verified January 2016

Source: ClinicalTrials.gov - January 21, 2016 Category: Research Source Type: clinical trials